New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export ALC’s income statement to Excel — free account
Alcon
ALCHealthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.
- Revenue
- +4.71%
- EPS
- +12.5%
- Free cash flow
- +13.3%
- Total debt
- +0.72%
Quarter to September 2026, against a year earlier
74.31
0.19
−0.26%
After hours trading: 74.32, up 0.01%, last trade 4:08pm Eastern.
Follow ALC
Alert me
Revenue to profit Fiscal 2025, year to Dec 31, 2025
Of every $100 of revenue, $9.42 was left as profit. What is an income statement?
| Revenue | 10.4 | 100.0% |
|---|---|---|
| Cost of revenue | −4.7 | −44.8% |
| Gross profit | 5.7 | 55.2% |
| Research & development | −1.0 | −9.5% |
| Selling, general & admin | −3.4 | −33.2% |
| Other operating costs | +0.1 | 0.5% |
| Operating income | 1.4 | 13.1% |
| Other income, net | −0.2 | −1.9% |
| Income tax | −0.2 | −1.7% |
| Net income | 1.0 | 9.4% |
Net margin (right axis)
| FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.2B | $7.5B | $6.8B | $8.3B | $8.7B | $9.5B | $9.9B | $10.4B |
| Operating income | −$248M | −$187M | −$482M | $580M | $672M | $1.0B | $1.4B | $1.4B |
| Net income | −$227M | −$656M | −$531M | $376M | $335M | $974M | $1.0B | $980M |
| Net margin (right axis) | −3.2% | −8.7% | −7.8% | 4.5% | 3.8% | 10.3% | 10.3% | 9.4% |
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue |
10,401.00 | 9,911.00 | 9,455.00 | 8,717.00 | 8,291.00 | 6,833.00 | 7,508.00 | 7,153.00 | 6,821.43 | 6,370.59 |
Revenue Growth |
4.94% | 4.82% | 8.47% | 5.14% | 21.34% | (8.99%) | 4.96% | 4.86% | 7.08% | (6.61%) |
Cost of Revenue |
4,656.00 | 4,399.00 | 4,208.00 | 3,969.00 | 3,639.00 | 3,893.00 | 3,846.00 | 3,961.00 | 3,604.08 | 3,365.69 |
Gross Profit |
5,745.00 | 5,512.00 | 5,247.00 | 4,748.00 | 4,652.00 | 2,940.00 | 3,662.00 | 3,192.00 | 3,218.37 | 3,004.90 |
R&D Expenses |
990.00 | 876.00 | 828.00 | 702.00 | 842.00 | 673.00 | 656.00 | 587.00 | 586.73 | 482.35 |
SG&A Expenses |
3,449.00 | 3,250.00 | 3,209.00 | 3,068.00 | 3,076.00 | 2,694.00 | 2,847.00 | 2,801.00 | 2,607.14 | 2,440.20 |
Operating Income |
1,360.00 | 1,413.00 | 1,039.00 | 672.00 | 580.00 | (482.00) | (187.00) | (248.00) | — | — |
Interest Expense (Operating) |
— | — | — | — | — | — | — | — | 27.55 | 30.39 |
Non-operating Income/Expense |
(200.00) | (157.00) | (207.00) | (209.00) | (162.00) | (153.00) | (145.00) | (52.00) | (23.47) | (90.20) |
Non-operating Interest Expenses |
204.00 | 192.00 | 189.00 | 134.00 | 120.00 | 124.00 | 113.00 | 24.00 | — | 0.98 |
| 1,160.00 | 1,256.00 | 832.00 | 463.00 | 418.00 | (635.00) | (332.00) | (300.00) | (127.55) | (108.82) | |
Income Tax Provision |
180.00 | 238.00 | (142.00) | 128.00 | 42.00 | (104.00) | 324.00 | (73.00) | (384.69) | 54.90 |
Income after Tax |
980.00 | 1,018.00 | 974.00 | 335.00 | 376.00 | (531.00) | (656.00) | (227.00) | — | — |
Net Income Common |
980.00 | 1,018.00 | 974.00 | 335.00 | 376.00 | (531.00) | (656.00) | (227.00) | 257.14 | (163.73) |
EPS (Basic) |
1.99 | 2.06 | 1.98 | 0.68 | 0.77 | (1.09) | (1.34) | (0.46) | 0.53 | (0.33) |
EPS (Diluted) |
1.98 | 2.05 | 1.96 | 0.68 | 0.76 | (1.09) | (1.34) | (0.46) | 0.53 | (0.33) |
Shares (Basic, Weighted) |
493.20 | 494.40 | 493.00 | 491.40 | 490.00 | 489.00 | 488.20 | 488.20 | 489.00 | 0.00 |
Shares (Diluted, Weighted) |
496.20 | 497.50 | 496.50 | 494.40 | 493.40 | 489.00 | 488.20 | 488.20 | 489.00 | 0.00 |
Gross Margin |
55.24% | 55.61% | 55.49% | 54.47% | 56.11% | 43.03% | 48.77% | 44.62% | 47.18% | 47.17% |
EBIT Margin |
13.08% | 14.26% | 10.99% | 7.71% | 7.00% | (7.05%) | (2.49%) | (3.47%) | (2.27%) | 0.31% |
EBT margin |
11.15% | 12.67% | 8.80% | 5.31% | 5.04% | (9.29%) | (4.42%) | (4.19%) | (1.87%) | (1.71%) |
Net Profit Margin |
9.42% | 10.27% | 10.30% | 3.84% | 4.54% | (7.77%) | (8.74%) | (3.17%) | 3.77% | (2.57%) |
Free Cash Flow Margin |
15.51% | 14.20% | 5.68% | 5.41% | 1.99% | 3.83% | 3.25% | 5.98% | 17.94% | 18.88% |
EBITDA |
2,551.00 | 2,639.00 | 2,265.00 | 1,783.00 | 1,800.00 | 1,144.00 | 1,269.00 | 1,374.00 | 1,233.67 | 1,254.90 |
EBIT |
1,360.00 | 1,413.00 | 1,039.00 | 672.00 | 580.00 | (482.00) | (187.00) | (248.00) | (155.10) | 19.61 |
Income from Continuous Operations |
980.00 | 1,018.00 | 974.00 | 335.00 | 376.00 | (531.00) | (656.00) | (227.00) | — | — |
Consolidated Net Income/Loss |
980.00 | 1,018.00 | 974.00 | 335.00 | 376.00 | (531.00) | (656.00) | (227.00) | 257.14 | (163.73) |
EPS (Basic, from Continuous Ops) |
1.99 | 2.06 | 1.98 | 0.68 | 0.77 | (1.09) | (1.34) | (0.46) | — | — |
EPS (Basic, Consolidated) |
1.99 | 2.06 | 1.98 | 0.68 | 0.77 | (1.09) | (1.34) | (0.46) | — | — |
EPS (Diluted, from Cont. Ops) |
1.98 | 2.05 | 1.96 | 0.68 | 0.76 | (1.09) | (1.34) | (0.46) | — | — |
Shares (Diluted, Average) |
496.20 | 497.50 | 496.50 | 491.40 | 493.40 | 489.00 | 488.20 | — | — | — |
EPS (Diluted, Consolidated) |
1.98 | 2.05 | 1.96 | 0.68 | 0.76 | (1.09) | (1.34) | (0.46) | — | — |
EBITDA Margin |
24.53% | 26.63% | 23.96% | 20.45% | 21.71% | 16.74% | 16.90% | 19.21% | 18.09% | 19.70% |
Operating Cash Flow Margin |
21.83% | 20.96% | 14.68% | 13.96% | 16.22% | 12.04% | 12.25% | 15.94% | 17.94% | 18.88% |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 19, 2026